One biotech and three SPACs went public this past week as the IPO market shows more signs of opening up. The VIX volatility index is hovering around 30, the IPO index is now up 58% from its March lows, and eight companies submitted initial filings, the most...read more
Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, raised $600 million by offering 60 million units at $10. The company originally planned to offer 40 million units before increasing its proposed unit offering to 50 million...read more
Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, raised the proposed deal size for its upcoming IPO on Friday. The Miami Beach, FL-based company now plans to raise $500 million by offering 50 million units at $10....read more
Lyra Therapeutics (LYRA) popped 16% in its IPO this past week, the latest biotech to surge in its public debut. It was joined by three SPACs, continuing an uptick in blank check activity. Despite enduring ...read more
US IPO Weekly Recap: Filing activity pops in a 1 IPO week
One biotech and three SPACs went public this past week as the IPO market shows more signs of opening up. The VIX volatility index is hovering around 30, the IPO index is now up 58% from its March lows, and eight companies submitted initial filings, the most...read more
Barry Sternlicht's SPAC Jaws Acquisition prices further upsized $600 million IPO at $10
Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, raised $600 million by offering 60 million units at $10. The company originally planned to offer 40 million units before increasing its proposed unit offering to 50 million...read more
Barry Sternlicht's SPAC Jaws Acquisition increases unit offering by 25% ahead of $500 million IPO
Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, raised the proposed deal size for its upcoming IPO on Friday. The Miami Beach, FL-based company now plans to raise $500 million by offering 50 million units at $10....read more
US IPO Weekly Recap: Biotech hot streak continues amid another wave of SPACs
Lyra Therapeutics (LYRA) popped 16% in its IPO this past week, the latest biotech to surge in its public debut. It was joined by three SPACs, continuing an uptick in blank check activity. Despite enduring ...read more